Efficacy of recombinant Newcastle disease virus, RAF-IL12 as a potential therapeutic cancer vaccine in CT26 and HT29 cancer cell line and in mouse model
Colon cancer remains one of the main cancer-causing death in men and women worldwide given that certain colon cancer subtypes are resistant to the conventional treatments and the development of new cancer therapy remains elusive. Alternative modalities such as the use of viral-based therapeutic canc...
Main Author: | Syed Najmuddin, Syed Umar Faruq |
---|---|
Format: | Thesis |
Language: | English |
Published: |
2019
|
Subjects: | |
Online Access: | http://psasir.upm.edu.my/id/eprint/90479/1/IB%202020%2021%20IR.pdf |
Similar Items
-
Safety and efficacy of recombinant newcastle disease virus expressing human interleukin-12 as a potential vaccine in breast cancer
by: Mohamed Amin, Zahiah
Published: (2019) -
Virus Newcastle (Baka/Strain Af-2240) Ekspresi Gen Hn Ke dalam Sel Kanser Colon Apoptotik Manusia (Ht-29)
by: Khodai, Samira
Published: (2009) -
Effect of Newcastle Disease Virus AF2240 on Allografted 4T1 Breast Cancer Cells in Balb/c Mice
by: Swaminathan, Setareh
Published: (2010) -
Effects of Velogenic Newcastle Disease Virus Strain AFF2240 on the Oncogenes and Marphological Changes of 4T1 Breast Cancer Cell in Balb/c Mice
by: Eshak, Zolkapli
Published: (2011) -
Engineering recombinant newcastle disease virus with pro-apoptotic gene to enhance oncolysis in selected colorectal cancer cells
by: Kalyanasundram, Jeevanathan
Published: (2020)